TM-N1324
CAS No. 1144477-35-9
TM-N1324 ( —— )
Catalog No. M26846 CAS No. 1144477-35-9
TM-N1324 is a GPR39 agonist. TM-N1324 activates human GPR39 with high efficacy and potencies of 280 nM and 9 nM in the absence and presence of Zn2+, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 56 | Get Quote |
|
5MG | 87 | Get Quote |
|
10MG | 170 | Get Quote |
|
25MG | 372 | Get Quote |
|
50MG | 556 | Get Quote |
|
100MG | 791 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTM-N1324
-
NoteResearch use only, not for human use.
-
Brief DescriptionTM-N1324 is a GPR39 agonist. TM-N1324 activates human GPR39 with high efficacy and potencies of 280 nM and 9 nM in the absence and presence of Zn2+, respectively.
-
DescriptionTM-N1324 is a GPR39 agonist. TM-N1324 activates human GPR39 with high efficacy and potencies of 280 nM and 9 nM in the absence and presence of Zn2+, respectively. TM-N1324 has similar potencies to murine GPR39 with EC50s of 180 nM and 5 nM, respectively.(In Vitro):Measurements of somatostatin confirms that the GPR39 agonist TM-N1324 increases somatostatin release by 53%. TM-N1324 is found to have promising in vitro ADME properties. TM-N1324 has reasonably good aqueous solubility (65 μM at pH 7.0).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorBTK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1144477-35-9
-
Formula Weight397.8
-
Molecular FormulaC18H13ClFN7O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1nn(c2N=C(O)CC(c12)c1ccc(F)cc1Cl)-c1ncnc2[nH]cnc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Valeria Di Battista, et al. Genetics and Pathogenetic Role of Inflammasomes in Philadelphia Negative Chronic Myeloproliferative Neoplasms: A Narrative Review. Int J Mol Sci
molnova catalog
related products
-
Astragaloside II
Astragaloside II is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy.
-
Irigenin
Irigenin has antifungal activity.
-
K-604
K-604 is a potent, selective and competitive ACAT-1 inhibitor with IC50 of 0.45 uM for human ACAT-1, displays 229-fold selectivity over ACAT-2.